Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Share News (COG)

Share Price Information for Cambridge Cog (COG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.00
Bid: 41.00
Ask: 43.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.878%)
Open: 42.00
High: 42.00
Low: 42.00
Prev. Close: 42.00
COG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Omega disputes repayment; BWA applies for licenses

Fri, 10th Dec 2021 15:03

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

Omega Diagnostics Group PLC - Alva, Scotland-based medical diagnostics company - Disagrees with request from the Department of Health & Social Care to repay pre-production payment of GBP2.5 million. The amount was originally paid as part of a contract inked in February this year, to provide the DHSC with manufacturing capacity for Covid-19 lateral flow antigen tests. However the DHSC was unable to move into phase 2 of the contract, which would have seen Omega progress to manufacturing tests using government-furnished equipment. Omega says it will continue to take further legal advice on the matter and hopes to reach a resolution swiftly.

Colin King, chief executive of Omega says: "It is clearly disappointing to receive this request for repayment given the efforts we have gone to ensure manufacturing capacity for Covid-19 lateral flow test was available for the DHSC and that we did not progress to Phase 2 of the contract due to the lack of confirmation from the DHSC regarding which test they require us to manufacture."

----------

Standard Life Investments Property Income Trust PLC - property investor - Completes purchase of two properties for GBP22.8 million total. The first is a property in St Helens, where Standard will fund the development of an industrial unit with a total commitment of GBP15.1 million. The second is an existing industrial unit in Washington let to Griffith Textile Machines until September 2035. The purchase price of GBP7.7 million reflects a net initial yield of 5.75%, company says. Both acquisitions are financed out of existing cash reserves.

----------

BWA Group PLC - London-based minerals exploration investment company focussed on Cameroon and Canada - Applies for two rutile sands exploration licences at Song-Loulou in Cameroon. The two areas, comprising a total of 992 square kilometres, are next to the firm's existing licence area at Nkoteng and are part of the same prospective river system. The application has been acknowledged by the Cameroon Ministry of Mines, Investment and Technological Development. BWA now has two exploration licences in Cameroon on which it is already working and is awaiting the issue of a total of five more rutile sands licences.

----------

Kenmare Resources PLC - lithium and zircon producer in Mozambique - Launches tender offer to raise GBP61.8 million. A total of 18.2 million shares are tendered by shareholders under the offer, with 14.8 million shares purchased at a price of GBP4.17 each.

----------

Starcrest Education Ltd - Cayman Islands-based developer and operator of education services - Cancels planned purchase of educational training and apprenticeships specialist National Training Company. Starcrest blamed market conditions for the deal falling through. In August, Starcrest outlined plans to buy the group through a reverse takeover, meaning its shares have remained suspended since then. Following the company's decision, trading in Starcrest's shares will begin again from Friday.

----------

DeepVerge PLC - York, England-based environmental & life science AI company - Completes development of the Microtox PD Covid detection system. Deepverge claims the product is able to detects SARS-CoV-2 and a range of pathogens at local, regional and national levels. The pandemic surveillance units will be launched in the first quarter of 2022.

Chief Executive Gerry Brandon comments: "Size, cost, reach and route to market have been heavily thought through with our new third generation designs. The units are now smaller - allowing them to be installed for smaller populations; mobile - allowing them to be taken to where populations gather; mass producible - allowing more affordability for customers; and just as importantly, available for new partner opportunities."

----------

LSL Property Services PLC - Newcastle-based estate agency - On Thursday, joint venture company Pivotal Growth completes purchase of Glasgow-based mortgage broker Lifetime Finance, marking its first acquisition. Pivotal Growth was established in April 2021 as a joint venture with Pollen Street Capital, with the aim to "buy and build" a leading national mortgage broker. It is planned that at least GBP200 million will be made available through equity and debt to fund acquisitions for Pivotal Growth.

"The Pivotal Growth management team is in active discussion with a number of other brokers that it believes would benefit considerably by being part of Pivotal Growth and we expect to confirm further deals in the early part of 2022," says LSL Chief Executive David Stewart.

----------

Cordel Group PLC - London-based artificial intelligence platform for transport corridor analytics, formerly called Maestrano - On Thursday notes expansion of contract with railroad customer in the US. Original contract saw Cordel's specialist rail analytics subsidiary, Cordel Technology, engineer the data capture process and artificial intelligence analysis of digital point clouds. Customer has now expanded the scope for data capture and analysis to up to 4,500 miles of track.

"We are excited to be moving forward with this expanded Pilot. The USA represents our largest growth opportunity and will provide a meaningful contribution to the group's performance in 2022," comments Chief Executive Nick Smith.

----------

Cambridge Cognition Holdings PLC - Cambridge, England-based digital neuroscience company - On Thursday wins GBP1.0 million schizophrenia clinical trial contract. Revenue from the contract is expected over the next three years. Cambridge Cognition will provide proprietary cognitive assessments and specialist, study management services as part of the agreement. The contract is a repeat purchase from an existing client that has contracted for several other clinical trials for schizophrenia. Chief Executive Matthew Stork states: "We are delighted to have formed an enduring partnership with this pharmaceutical company that recognises the potential for our sensitive cognitive assessments to be used in pivotal clinical trials. This continues to be an exciting area for potential further growth for the company in the future."

----------

Miton Global Opportunities PLC - investor in closed-end investment funds on London Stock Exchange - Changes name to MIGO Opportunities Trust in order to make it easier for potential investors to find and identify the company and to "promote its success in the interests of all shareholders".

----------

Tectonic Gold PLC - Sydney-based exploration company - Announces recent drilling campaign completed 75% of planned program but was cut short due to weather. Able to extract enough data with confirmed gold intersections to advance geological modelling. Now in discussions with potential partners and preparing drilling plans for 2022 and 2023. States the company is fully funded to return to the field and complete final drilling.

----------

By Will Paige; willpaige@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
19 Dec 2018 08:52

Cambridge Cognition shares tumble as revenues fall short of expectations

(Sharecast News) - Neuroscience technology developer Cambridge Cognition has seen revenues fall short of expectations and losses widen as a result of a switch in accounting practices.

Read more
20 Sep 2018 12:35

Cambridge Cognition Holdings Loss Widens As Revenue Drops

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Thursday that its loss for the first half of the financial year widened as it recorded a drop in revenue as a result of the new IFRS

Read more
19 Sep 2018 12:45

Cambridge Cognition To Provide NeuroVocalix For Virtual Clinical Tests

LONDON (Alliance News) - Cambridge Cognition Holdings PLC on Wednesday said it signed its first commercial contract with an undisclosed pharmaceutical firm for its recently launched NeuroVocalix a

Read more
19 Sep 2018 10:14

Cambridge Cognition announces first NeuroVocalix commercial partnership

(Sharecast News) - Neuroscience technology company Cambridge Cognition Holdings announced its first commercial partnership for its recently launched 'NeuroVocalix' voice biomarker technology on Wednesday.

Read more
13 Sep 2018 11:14

Cambridge Cognition's NeuroVocalix Set For Clinical Trial Use

LONDON (Alliance News) - Neuroscience technology firm Cambridge Cognition Holdings PLC on Thursday said its NeuroVocalix platform is ready for clinical trials.NeuroVocalix, the company to a

Read more
1 Aug 2018 11:51

Cambridge Cognition Inks US Production Distribution For CANTAB

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Wednesday that it signed a commercial collaboration with health provider Healthy Amplified to launch its software product to better a

Read more
17 May 2018 16:01

UK Shareholder Meetings Calendar - Next 7 Days

Friday 18 MayPaddy Power BetfairIndependent News & (T)PetrofacJohn Group (re by

Read more
22 Mar 2018 13:03

Cambridge Cognition Shares Fall As It Swings To Annual Loss

LONDON (Alliance News) - Shares fell in Cambridge Cognition Holdings PLC on Thursday as it swung to a loss in 2017 from a maiden profit due to higher costs and lower in the at

Read more
14 Mar 2018 12:47

Oil majors give in to investors with share buyback spree

By Nivedita Bhattacharjee March 14 (Reuters) - After almost three barren years for investors who have poured millions into the U.S. oil sector, producers are finally to

Read more
25 Jan 2017 08:27

Cambridge Cognition gains US regulatory approval for memory test

(ShareCast News) - Neuroscience digital health company Cambridge Cognition has gained regulatory clearance for its memory test to be used as a medical device in the US. Cantab Mobile, which detects clinically-relevant memory impairment in older adults at the point of care, received 510k clearance fo

Read more
13 Oct 2016 10:55

Cambridge Cognition confirms series of new contracts

(ShareCast News) - Neuroscience company Cambridge Cognition Holdings announced a series of new contracts worth more than £0.25m on Thursday, to assess - through CANTAB Connect - the abuse potential of investigational drugs in a new market application for the company. The AIM-traded firm claimed that

Read more
22 Sep 2016 10:23

Cambridge Cognition's sales up after investments in marketing

(ShareCast News) - Cambridge Cognition' half-year revenues grew and losses were more than halved as the neuroscience software and hardware company's invested in marketing and development. For the six months ended 30 June, revenue increased by 11.3% to £3.26, compared to the same period last year. T

Read more
22 Sep 2016 08:51

Cambridge Cognition Loss Narrows On Strong Revenue Growth

Read more
20 Sep 2016 08:07

Cambridge Cognition Inks First Contract For CANTAB Recruit Product

Read more
16 Aug 2016 13:49

Cambridge Cognition announces promising results from technology study

(ShareCast News) - Neuroscience company Cambridge Cognition Holdings announced results on Tuesday from a new technology feasibility study. The AIM-traded firm, which develops and markets near-patient technologies for the assessment of brain health to improve the drug development process, said the re

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.